MedPath

WHITBY: Working Towards Better Healthcare Interventions for Tinnitus: a Brain Stimulation StudY

Not Applicable
Not yet recruiting
Conditions
Tinnitus
Interventions
Device: transcranial Direct Current Stimulation
Registration Number
NCT06628414
Lead Sponsor
University of Nottingham
Brief Summary

Tinnitus - the awareness of sound without any outside source - affects around 15% of people and can cause anxiety and depression. Treatment options are limited and do not address tinnitus directly (e.g., reduce its loudness). To do that, we must change brain activity causing tinnitus. Low-dose electrical stimulation, using a technique called transcranial Direct Current Stimulation (tDCS), is a promising approach. The technique is safe and easy to administer. Several small studies have tested tDCS for tinnitus showing some benefits.

To assess whether these benefits will generalise to other patients, we need to conduct a randomised controlled trial - a large, rigorously controlled experiment based on prior agreed procedures. Clinical trials are expensive and time-consuming to run and thus require meticulous pilot work to establish the most effective treatment regimens and the most sensitive measures of treatment outcome. The current study aims to provide such pilot information for a clinical trial of tDCS treatment of tinnitus. Using a total of 40 patients, we will establish how to best to administer tDCS and measure resulting changes in tinnitus perception and associated brain activity.

The current study is a crucial first step towards determining whether or not tDCS can effectively treat tinnitus.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Aged 18 or over
  • Suffering from subjective idiopathic tinnitus
  • Sufficient understanding of English to be able to provide informed consent
  • Able to safely undergo tDCS
Exclusion Criteria
  • Aged under 18
  • Not suffering from tinnitus or suffering from objective tinnitus
  • Insufficient understanding of English to be able to provide informed consent
  • Unable to safely undergo tDCS as assessed by tDCS Safety Questionnaire
  • Having taken part in a research study in the last 3 months involving invasive procedures or an inconvenience allowance

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Transcranial Direct Current Stimulation (tDCS)transcranial Direct Current StimulationTDCS will be delivered using a NeuroConn DC Stimulator Plus via two 35cm2 rubber electrodes covered in saline-soaked sponges. The anode electrode will be positioned over EEG 10-20 coordinate F4 and the cathode over F3. The current will be delivered at 2mA for 20 minutes with ramp-up and ramp-down of 10 seconds. Each participant will receive 10 daily stimulation sessions over 2 weeks.
Shamtranscranial Direct Current StimulationSame as intervention arm but the current will be delivered at 2mA for 30 seconds, after which the stimulation will be discontinued.
Primary Outcome Measures
NameTimeMethod
Proof of conceptAssessed at study end (anticipated as 1 year after study start)

Measured by protocol compliance and attrition

Secondary Outcome Measures
NameTimeMethod
Tinnitus symptom severityBefore first intervention session, after final intervention session and at 3-month follow-up

Measured by Tinnitus Functional Index (TFI); maximum score: 100, higher score indicates greater tinnitus symptom severity

Tinnitus loudnessBefore first intervention session, after each intervention session and at 3-month follow-up (VAS). Before first intervention session and after final intervention session (loudness matching)

Measured by 10-point visual analogue scale, higher score indicates higher tinnitus loudness and by audiometric tinnitus loudness matching, with higher dB indicating higher loudness

DepressionBefore first intervention session, after final intervention session and at 3-month follow-up

Measured by Patient Health Questionnaire (PHQ-9) scores can range from 0 to 27 with a higher score indicating more severe symptoms

AnxietyBefore first intervention session, after final intervention session and at 3-month follow-up

Measured by Generalised Anxiety Disorder Assessment (GAD-7) scored from 0 to 21, with a higher score indicating more severe anxiety

Treatment satisfactionAfter final intervention session and at 3-month follow-up

Measured by Short Assessment of Patient Satisfaction (SAPS) scores can range from 0 to 28 with higher scores indicating greater satisfaction

Adverse effectsAfter each intervention session (10 sessions over 2 weeks)

Measured by in-house adverse effects questionnaire without numerical scoring system.

Electrophysiological brain activityBefore first intervention session and after final intervention session (1st and 10th of 10 sessions over 2 weeks)..

Spontaneous oscillatory and auditory-evoked brain activity and coherence will be measured using 32-channel EEG. We will acquire basic structural brain images on a subset of 10 representative subjects to test the feasibility of creating individualised head models for EEG source imaging and tDCS current flow modelling.

© Copyright 2025. All Rights Reserved by MedPath